Skip to main content

Eargo, Inc.

EARDelisted Feb 16, 2024
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001719395

Eargo, Inc. was delisted on Feb 16, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 23 institutions reported holding it in 13F filings for Q4 2023, worth $44.2M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Eargo, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of EAR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Of which not filed for Q1 2023Q1 2023Change
Holders42124−17
SharesConverted for a 1-for-20 split17.0M1.65K16.8M−206.6K (−1.2%)
Value$195.9M$19.0K$78.7M−$117.1M (−59.8%)

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (3)

Institutions that held Eargo, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to EAR in Q1 2023
InstitutionSharesValue% of portfolio
Nantahala Capital Management, LLC54,002$252.7K0.02%
Federated Hermes, Inc.101$4730.00%
JPMorgan Chase & Co82$3840.00%

Sold out (20)

Institutions that held Eargo, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Not filed for Q1 2023 yet (1)

Institutions that held Eargo, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EAR in Q4 2022 that haven't filed for Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Gofen & Glossberg LLC33,062$19.0K